Literature DB >> 21830008

Cofactors in human papillomavirus infection and cervical carcinogenesis.

Hakan Yetimalar1, Burcu Kasap, Kulal Cukurova, Askin Yildiz, Adnan Keklik, Ferit Soylu.   

Abstract

OBJECTIVE: This study aimed to identify the effect of various risk factors as the promoters of HPV infection, and to identify which HPV-positive women may have an increased risk of developing cervical cancer.
METHODS: Smear preparations were examined and classified according to the Bethesda system. HPV-DNA detection and genotyping was carried out using polymerase chain reaction combined with reverse hybridization line-probe assays. Age, smoking habit, age at first sexual intercourse, number of sexual partners, number of term births, contraceptive method, progesterone therapy, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were recorded.
RESULTS: 642 women (96 women with abnormal cervical cytology and 546 women with normal cytology) provided cervical samples. Smoking habit, number of sexual partners, number of term births, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as the promoters of HPV infection. History of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as cofactors affecting progression from HPV infection to cervical cancer. Neither of contraceptive methods studied was related to HPV infection or coexistence with malign transformation to cervical cancer.
CONCLUSION: Information gathered from this study could be used to prioritize limited screening and treatment services to woman who have specific characteristics that may put them at an increased risk of HPV infection. Additionally, by identifying which women have a higher risk of cervical cancer; it may be possible to reduce the number of unnecessary colposcopies.

Entities:  

Mesh:

Year:  2011        PMID: 21830008     DOI: 10.1007/s00404-011-2034-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  9 in total

1.  Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.

Authors:  Jing Yang; Wei Wang; Zhe Wang; Zhilian Wang; Yonghong Wang; Jintao Wang; Weihong Zhao; Dongyan Li; Huiqiang Liu; Min Hao
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

Review 2.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

3.  p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.

Authors:  Lu-Lu Yu; Hui-Qin Guo; Xiao-Qin Lei; Yu Qin; Ze-Ni Wu; Le-Ni Kang; Xun Zhang; You-Lin Qiao; Wen Chen
Journal:  Oncotarget       Date:  2016-10-04

4.  Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.

Authors:  Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Lifang Hou; Robert L Murphy; Isaac F Adewole; Melissa A Simon
Journal:  BMC Health Serv Res       Date:  2018-11-22       Impact factor: 2.655

5.  HPV infection and cervical neoplasia: associated risk factors.

Authors:  Andrea Alves Ribeiro; Maria Cecília Costa; Rosane Ribeiro Figueiredo Alves; Luísa Lina Villa; Vera Aparecida Saddi; Megmar Aparecida Dos Santos Carneiro; Luiz Carlos Zeferino; Sílvia Helena Rabelo-Santos
Journal:  Infect Agent Cancer       Date:  2015-05-26       Impact factor: 2.965

6.  Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil.

Authors:  P M Miranda; N N T Silva; B C V Pitol; I D C G Silva; J L Lima-Filho; R F Carvalho; R C Stocco; W Beçak; A A Lima
Journal:  Biomed Res Int       Date:  2013-11-05       Impact factor: 3.411

7.  HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.

Authors:  Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Olugbenga Silas; Atiene S Sagay; Rose Anorlu; Supriya D Mehta; Firas Wehbe; Melissa A Simon; Isaac F Adewole; Lifang Hou; Robert L Murphy
Journal:  Infect Agent Cancer       Date:  2019-11-29       Impact factor: 2.965

8.  [Sexual risk behaviours and PAP testing in university women vaccinated against human papillomavirus].

Authors:  Ana Fernández-Feito; Raquel Antón-Fernández; María Paz-Zulueta
Journal:  Aten Primaria       Date:  2017-09-01       Impact factor: 1.137

Review 9.  Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite.

Authors:  Johannes Huber; Anna Mueller; Manuela Sailer; Pedro-Antonio Regidor
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.